Simplex Trading
ORTX

Simplex Trading’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Simplex Trading’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-187
Closed -$827 – 10815
2022
Q3 		$0 Buy
187
+100
+115% +$557 ﹤0.01% 11184
2022
Q2 		$0 Buy
+87
New +$491 ﹤0.01% 11446
2022
Q1 		– Sell
-1,777
Closed -$17.4K – 11674
2021
Q4 		$23K Sell
1,777
-4,145
-70% -$68.5K ﹤0.01% 8229
2021
Q3 		$254K Hold
5,922
– – ﹤0.01% 5208
2021
Q2 		$259K Buy
5,922
+4,376
+283% +$244K ﹤0.01% 5232
2021
Q1 		$112K Buy
1,546
+106
+7% +$7.53K ﹤0.01% 5599
2020
Q4 		$62K Buy
1,440
+1,302
+943% +$58.3K ﹤0.01% 5960
2020
Q3 		$5K Buy
138
+126
+1,050% +$6.51K ﹤0.01% 7151
2020
Q2 		$0 Buy
+12
New +$1.1K ﹤0.01% 8582

Simplex Trading's ORTX Position: Q4 2022 in Review

Simplex Trading sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q4 2022, closing a stake of 187 shares — an estimated $827 sold.

Simplex Trading first reported a position in ORTX in Q2 2020 and held it in 9 quarters. The position peaked at $259K in Q2 2021. 47 funds tracked by Wall St. Rank hold ORTX as of Q4 2022.

  • Simplex Trading reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q4 2022 after selling out during the quarter.
  • Simplex Trading sold 187 Orchard Therapeutics plc American Depositary Shares shares in Q4 2022, an estimated $827.
  • Simplex Trading first reported a position in Orchard Therapeutics plc American Depositary Shares in Q2 2020 and held it in 9 quarters.
  • Simplex Trading's Orchard Therapeutics plc American Depositary Shares position peaked at $259K in Q2 2021.
  • 47 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q4 2022.

Based on Simplex Trading's 13F filing for Q4 2022, filed 2 Feb 2023.